UCB
The Global Access Strategy Head at UCB will lead the development and execution of global access, pricing, payer evidence, and healthcare policy strategies for a key asset throughout its lifecycle. Working within a cross‑functional Global Asset Team, the role partners with market access, medical affairs, commercial, and policy experts to integrate payer insights into strategic decisions and support launch readiness worldwide.
Headquarters
Brussels, Brussels, Belgium
Company Size
5001-10000 employees
Founded
1928
UCB a global biopharmaceutical leader focuses on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for UCB.
UCB didn’t post a salary, so this is our estimate from similar listings.
16% above the average for this role
Global Access Strategy Lead (Belgium)
City of Winnipeg
Global Access Strategy Lead (Belgium)
City of Pierre, South Dakota
Global Access Strategy Lead (UK)
City of Pierre, South Dakota
Director, Global Market Access and Pricing Strategy Oncology – Pumitamig
Bristol Myers Squibb
Global Access Strategy Lead (UK)
City of Winnipeg
Director, Global Pricing and Market Access Strategy Lead Immunology
Bristol Myers Squibb